This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Eirgen Pharma Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Pawel Dominik Buczek: Innovator in Peptide Analog Formulations
Introduction
Pawel Dominik Buczek is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of peptide analog formulations aimed at treating diabetes and obesity.
Latest Patents
Pawel Buczek holds a patent for "Oxyntomodulin peptide analog formulations." This invention relates to GLP-1 and/or glucagon receptor agonists, specifically oxyntomodulin peptide analogs. The patent encompasses pharmaceutically acceptable salts, formulations comprising these analogs, and their uses for treating diabetes and associated diseases or disorders. He has 1 patent to his name.
Career Highlights
Pawel Buczek is currently employed at Eirgen Pharma Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective treatments that can significantly improve the quality of life for individuals suffering from metabolic disorders.
Collaborations
Throughout his career, Pawel has collaborated with esteemed colleagues, including Bruce Peter Connop and Dorothy Melissa Lynn Spencer. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Pawel Dominik Buczek is a dedicated inventor whose work in peptide analog formulations is paving the way for new treatments in diabetes and obesity. His contributions to the field are invaluable and reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile